Autoimmune encephalitis: an observational study from South India

Table 2 Studies from India with AE cohorts

S. No	Investigators and year	Place	AE number	Antibody distribution
1	Cyril and colleagues [8], 2009–2013	Trivandrum	14	14 NMDA
2	Kamble and colleagues [9], 2011–2015	Bangalore	16	10 NMDA, 4 anti-TPO, 2 Lgi1
3	Sudan and colleagues [10], 2011–2014	Kochi	13	13 NMDA
4	Dash and colleagues [11], 2013–2016	Delhi	41	24 NMDA, 12 LGi1; 5 GAD
5	Kannoth and colleagues [12], 2013–2016	Kochi	54	34 Lgi1; 13 CASPR2; 7 Both
6	Chandra and colleagues [13], 2013–2018	Bangalore	29	29 NMDA
7	Shivaraman and colleagues [14], 2014–2020	Bangalore	16	16 CASPR2
8	Raja and colleagues [15], 2018–2020	Bangalore	28	28 NMDA
9	Datta and colleagues [16] 2018–2020	Kolkatta	25	25 NMDA

AE – Autoimmune Encephalitis; CASPR2 – Contactin-associated protein-like 2; GAD – Glutamic acid decarboxylase; LGi1 – Leucine-rich glioma inactivated NMDA – N-Methyl-D Aspartate Receptor; TPO—thyroid peroxidase VGKC – Voltage-gated potassium channels